Quantcast

Wearing Orange Glasses in the Evening to Maximize Melatonin May Help Avoid Alzheimer’s Disease

May 8, 2012

Recent studies show melatonin helps prevent and treat Alzheimer´s disease. Special glasses from LowBlueLights.com (Photonic Developments LLC) that block blue light, worn for a few hours before bedtime, make it possible to increase the time when melatonin is present from 7 or 8 hours to 11 or12 hours. This may shift the balance in favor of health.

University Heights, OH (PRWEB) May 07, 2012

In recent papers from Italy, Russia and the US, scientists have described the possible benefits of melatonin in avoiding and treating Alzheimer´s disease. Wearing special glasses that block the blue light known to suppress melatonin allows it to flow as if in darkness. In this way the glasses available at LowBlueLights.com allow the body to produce melatonin for the 11-12 hours known to be possible. Because of exposure to light in the hours before bedtime, most Americans only make melatonin for 7 or 8 hours a night.

A recent study(1) of the spinal fluid that bathes the brain suggests this difference in the time that the pineal gland makes melatonin (and other antioxidants) may reduce the probability for the formation of the plaques (2) associated with Alzheimer´s disease. Studies in animals and humans show that the concentration of melatonin in the spinal fluid is significantly higher than in the blood. Melatonin is thought to be the unique antioxidant that protects the brain from damage by eliminating the free radicals that can damage the brain cells.

For information contact Richard L. Hansler PhD 216 397 1657 or rhansler(at)jcu(dot)edu.

(1)

Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system. PMID: 21358967 [Pubmed

(2)

Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.PMID: 21358971 [PubMed

For the original version on PRWeb visit: http://www.prweb.com/releases/prweblowbluelight/lowbluelights/prweb9448102.htm


Source: prweb



comments powered by Disqus